What is the interpretation and recommended management of thyroid function tests showing T3 1.3 ng/mL, T4 11.5 µg/dL, and TSH 5 µIU/mL in a 5‑day‑old term male infant weighing 3 kg?

Management of Elevated TSH in a 5-Day-Old Term Neonate

This infant requires immediate confirmatory venous thyroid function testing (serum TSH and free T4) and should be seen urgently within 24 hours, but treatment should NOT be started yet because the TSH of 5 µIU/mL falls below the threshold requiring immediate intervention. 1

Interpretation of Current Results

The thyroid function tests show:

• TSH 5 µIU/mL: Mildly elevated (normal newborn range typically <4-5 µIU/mL at day 5)
• T4 11.5 µg/dL: Within normal range for age (normal ~10-16 µg/dL in first week)
• T3 1.3 ng/mL: Within normal range for newborns

This pattern suggests mild hyperthyrotropinemia with compensated thyroid function—the thyroid is producing adequate hormone but requiring slightly elevated TSH stimulation.

Immediate Action Required

Confirmatory Venous Testing

• Obtain venous blood sample for serum free T4 (FT4) and TSH within 24 hours 1
• Do not rely solely on capillary/screening values for treatment decisions
• Ensure at least 4 hours have passed since any feeding (though this is less critical in newborns)

Treatment Decision Algorithm Based on Venous Results:

If venous FT4 is LOW (below age-specific norms):

• Start levothyroxine immediately, regardless of TSH level 1
• This prevents neurodevelopmental damage

If venous TSH ≥20 mIU/L:

• Start treatment even if FT4 is normal 1
• High likelihood of decompensated hypothyroidism

If venous TSH is 6-20 mIU/L with normal FT4 (most likely scenario for this infant):

• Do NOT start treatment immediately 1
• Perform diagnostic imaging (thyroid ultrasound ± scintigraphy) to establish etiology 1
• Recheck thyroid function in 2 weeks 1
• If TSH remains elevated >6 mIU/L for 3-4 weeks, discuss with family either:
  • Starting levothyroxine with plan to retest off treatment later, OR
  • Continue monitoring every 2 weeks without treatment 1

If venous TSH <6 mIU/L with normal FT4:

• Likely transient TSH elevation
• Recheck in 2-4 weeks to confirm normalization

Critical Considerations for This Specific Case

Why This Infant Needs Careful Follow-up:

1. Day 5 of life timing: The physiological TSH surge peaks at 24-72 hours and should be declining by day 5. A TSH of 5 at this age warrants investigation 1

2. Term infant, appropriate weight (3 kg): No special risk factors like prematurity, low birth weight, or NICU admission that would mandate second screening 1

3. Normal T4 level: Suggests the thyroid gland is currently producing adequate hormone, making severe congenital hypothyroidism less likely

Common Pitfalls to Avoid:

• Do not start treatment based on screening values alone without venous confirmation 1
• Do not delay venous testing—see the infant within 24 hours 1
• Do not use TSH <40 mIU/L as reassurance to avoid follow-up; the 6-20 mIU/L range requires monitoring 1
• Do not assume this is transient without documented normalization on repeat testing
• Do not order only TSH on follow-up—always measure both TSH and FT4 together 1

Differential Diagnosis

The mild TSH elevation with normal T4 could represent:

1. Transient hyperthyrotropinemia (most common)—resolves spontaneously
2. Mild permanent congenital hypothyroidism with eutopic thyroid gland
3. Subclinical hypothyroidism—may progress or remain stable
4. Maternal thyroid antibodies (less likely with normal T4)
5. Iodine deficiency or excess (geographic/dietary factors)

Additional Workup

• Thyroid ultrasound: Assess gland size, location, and morphology 1
• Physical examination: Check for dysmorphic features, cardiac abnormalities, and other congenital malformations that associate with congenital hypothyroidism 1
• Maternal thyroid history: Ask about maternal thyroid disease, medications, and iodine exposure

Why Not Treat Immediately?

The European Society for Paediatric Endocrinology guidelines are clear that treatment is not indicated for TSH 5-6 mIU/L with normal FT4 1. The critical period for neurodevelopment means we must treat true hypothyroidism aggressively, but overtreatment of transient or mild elevations can cause harm. The TSH threshold of 6-20 mIU/L represents a gray zone requiring observation, not immediate intervention, when FT4 is normal.

The priority is confirming the diagnosis with venous testing and establishing whether this represents transient physiology or true thyroid dysfunction requiring treatment.